Chromatin remodeling and leukemia: new therapeutic paradigms. [electronic resource]
Producer: 19990805Description: 417-28 p. digitalISSN:- 0006-4971
- Acetylation
- Antineoplastic Agents -- therapeutic use
- Cell Differentiation -- drug effects
- Chromatin -- metabolism
- Chromosomal Proteins, Non-Histone -- physiology
- Core Binding Factor Alpha 2 Subunit
- DNA-Binding Proteins -- genetics
- Enzyme Inhibitors -- therapeutic use
- Gene Expression Regulation, Leukemic
- Histone Deacetylase Inhibitors
- Histone-Lysine N-Methyltransferase
- Histones -- chemistry
- Humans
- Leukemia -- genetics
- Leukemia, Promyelocytic, Acute -- drug therapy
- Models, Genetic
- Myeloid-Lymphoid Leukemia Protein
- Neoplasm Proteins -- physiology
- Nucleic Acid Conformation
- Nucleosomes -- ultrastructure
- Oncogene Proteins, Fusion -- physiology
- Protein Processing, Post-Translational
- Proto-Oncogenes
- RUNX1 Translocation Partner 1 Protein
- Recombinant Fusion Proteins -- physiology
- Static Electricity
- Transcription Factors -- physiology
- Translocation, Genetic
- Tretinoin -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review
There are no comments on this title.
Log in to your account to post a comment.